![](https://i.imgur.com/CLvY2jA.png")
10-05-2022, 07:29 AM
Nationwide infections up 22% from last week: CDC
WASHINGTON -- As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug.
Doctors have started reporting rare cases of patients whose symptoms return several days after completing Paxlovid's five-day regimen of pills. That's prompted questions about whether those patients are still contagious and should receive a second course of Paxlovid.
https://abcnews.go.com/Health/wireStory/...l-84596614
WASHINGTON -- As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug.
Doctors have started reporting rare cases of patients whose symptoms return several days after completing Paxlovid's five-day regimen of pills. That's prompted questions about whether those patients are still contagious and should receive a second course of Paxlovid.
https://abcnews.go.com/Health/wireStory/...l-84596614
